Therma Bright Inc. THRM

Updated: 14 Jun 2026

TSX-V | Biotech | Medical technology and diagnostics

No signal published yet

We already track Therma Bright and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Therma Bright free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
TSX-V
Type
Biotech
Sector
Medical technology and diagnostics
We're already tracking Therma Bright Inc. — here are the latest events we've registered

Recent News

  • On May 5, 2026, the company announced a follow-on order for 100 Venowave units from Horizon Health. This order follows an initial shipment in March 2026 and indicates growing traction for the device within the U.S. vascular health market.

What Firelda Watch includes for Therma Bright Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Therma Bright Inc. will be delivered in the same format.

Want to follow Therma Bright Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Therma Bright free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Therma Bright Inc. THRM
Therma Bright — follow and we'll monitor it
Follow Therma Bright free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.